Bird Flu (H5N1 Avian Influenza) Vaccine Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age
Condition: InfluenzaIntervention: Biological: Influenza A (H5N1) Virus monovalent vaccine (GSK1557484A).Sponsor: GlaxoSmithKlineNot yet recruiting - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2016 Category: Research Source Type: clinical trials
